Upregulation of cytochrome P450 2J3/11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway

Cytokine

Volumn 60, Issue 2, 2012, Pages 360-368

  Wang, Hong Xia ^a   Zhang, Dong Mei ^b   Zeng, Xiang Jun ^a   Mu, Jing ^c   Yang, Hui ^a   Lu, Ling Qiao ^a   Zhang, Li Ke ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Xuwu TCM Hospital   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

11,12 EET; Apoptosis; Cytochrome P450 2J3; Ischemia; Postconditioning

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; CASPASE 3; CYTOCHROME C; CYTOCHROME P450; CYTOCHROME P450 CYP2J3; EPOXYICOSATRIENOIC ACID; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REOXYGENATION; WESTERN BLOTTING;

8,11,14-EICOSATRIENOIC ACID; AMIDES; ANIMALS; ANIMALS, NEWBORN; ANOXIA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL SURVIVAL; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES C; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCYTES, CARDIAC; OXYGEN; RATS; RATS, WISTAR; UP-REGULATION;

RATTUS;

EID: 84866762586     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.029     Document Type: Article

References (39)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
2. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285:H579-H588.
3. Kin H., Zhao Z.Q., Sun H.Y., Wang N.P., Corvera J.S., Halkos M.E., et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004, 62:74-85.
4. Tsang A., Hausenloy D.J., Mocanu M.M., Yellon D.M. Postconditioning: a form of ''modified reperfusion'' protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004, 95:230-232.
5. Skyschally A., Van C.P., Iliodromitis E.K., Schulz R., Kremastinos D.T., Heusch G. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 2009, 104:469-483.
6. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004, 44:1103-1110.
7. Iliodromitis E.K., Georgiadis M., Cohen M.V., Downey J.M., Bofilis E., Kremastinos D.T. Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res Cardiol 2006, 101:502-507.
8. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., et al. Postconditioning the human heart. Circulation 2005, 112:2143-2148.
9. Yu G.G., Zeng X.J., Wang H.X., Lu L.Q., Zheng S.P., Ma L.Q., et al. Cytochrome P450 2J3/epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat. Clin Exp Pharmacol Physiol 2011, 38:63-70.
10. Penna C., Rastaldo R., Mancardi D., Raimondo S., Cappello S., Gattullo D., et al. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K(+) channel and protein kinase C activation. Basic Res Cardiol 2006, 101:180-189.
11. Argaud L., Gateau-Roesch O., Augeul L., Couture-Lepetit E., Loufouat J., Gomez L., et al. Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts. Am J Physiol Heart Circ Physiol 2008, 294:H386-H391.
12. Sun H.Y., Wang N.P., Kerendi F., Halkos M., Kin H., Guyton R.A., et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005, 288:H1900-H1908.
13. Bopassa J.C., Ferrera R., Gateau-Roesch O., Couture-Lepetit E., Ovize M. PI3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 2006, 69:178-185.
14. de Moissac D., Gurevich R.M., Zheng H., Singal P.K., Kirshenbaum L.A. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 2000, 32:53-63.
15. Borutaite V., Budriunaite A., Morkuniene R., Brown G.C. Release of mitochondrial cytochrome c and activation of cytosolic caspases induced by myocardial ischaemia. Biochim Biophys Acta 2001, 1537:101-109.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
17. Yue H., Strauss K.I., Borenstein M.R., Barbe M.F., Rossi L.J., Jansen S.A. Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 803:267-277.
18. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate forming lipophilic cation JC-1. Proc Natl Acad Sci U S A 1991, 88:3671-3675.
19. Boengler K., Hilfiker-Kleiner D., Heusch G., Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010, 105:771-785.
20. Feeney C.J., Pennefather P.S., Gyulkhandanyan A.V. A cuvette-based fluorometric analysis of mitochondrial membrane potential measured in cultured astrocyte monolayers. J Neurosci Methods 2003, 125:13-25.
21. Sinal C.J., Miyata M., Tohkin M., Nagata K., Bend J.R., Gonzalez F.J. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 2000, 275:40504-40510.
22. Seubert J., Yang B., Bradbury J.A., Graves J., Degraff L.M., Gabel S., et al. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+channels and p42/p44-MAPK pathway. Circ Res 2004, 95:506-514.
23. Gross G.J., Falck J.R., Gross E.R., Isbell M., Moore J., Nithipatikom K. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. Cardiovasc Res 2005, 68:18-25.
24. Gross G.J., Gauthier K.M., Moore J., Campbell W.B., Falck J.R., Nithipatikom K. Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog. Am J Physiol Heart Circ Physiol 2009, 297:H47-H52.
25. Batchu S.N., Law E., Brocks D.R., Falck J.R., Seubert J.M. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J Mol Cell Cardiol 2009, 46:67-74.
26. Rosolowsky M., Falck J.R., Willerson J.T., Campbell W.B. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res 1990, 66:608-621.
27. Nithipatikom K., DiCamelli R.F., Kohler S., Gumina R.J., Falck J.R., Campbell W.B., et al. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Anal Biochem 2001, 292:115-124.
28. Dhanasekaran A., Gruenloh S.K., Buonaccorsi J.N., Zhang R., Gross G.J., Falck J.R., et al. Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol 2008, 294:H724-35.
29. Chen J.K., Capdevila J., Harris R.C. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 2001, 21:6322-6331.
30. Dhanasekaran A., Al-Saghir R., Lopez B., Zhu D., Gutterman D.D., Jacobs E.R., et al. Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature. Am J Physiol Heart Circ Physiol 2006, 291:H517-31.
31. Yang S., Lin L., Chen J.X., Lee C.R., Seubert J.M., Wang Y., et al. Cytochrome P450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-α via MAPK and PI3K/Akt signaling pathways. Am J Physiol Heart Circ Physiol 2007, 293:H142-H151.
32. Ussher J.R., Lopaschuk G.D. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc Res 2008, 79:259-268.
33. Stanley W.C., Morgan E.E., Huang H., McElfresh T.A., Sterk J.P., Okere I.C., et al. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. Am J Physiol Heart Circ Physiol 2005, 289:H2304-9.
34. Cohen M.V., Downey J.M. Ischemic postconditioning: from receptor to end-effector. Antioxid Redox Signal 2011, 4:821-831.
35. Paillard M., Gomez L., Augeul L., Loufouat J., Lesnefsky E.J., Ovize M. Postconditioning inhibits mPTP opening independent of oxidative phosphorylation and membrane potential. J Mol Cell Cardiol 2009, 46:902-909.
36. Katragadda D., Batchu S.N., Cho W.J., Chaudhary K.R., Falck J.R., Seubert J.M. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells. J Mol Cell Cardiol 2009, 46:867-875.
37. Batchu S.N., Lee S.B., Qadhi R.S., Chaudhary K.R., El-Sikhry H., Kodela R., et al. Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. Br J Pharmacol 2011, 162:897-907.
38. Lu T., Hoshi T., Weintraub N.L., Spector A.A., Lee H.C. Activation of ATP-sensitive K+ channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes. J Physiol 2001, 537:811-827.
39. Lu T., Vanrollins M., Lee H.C. Stereospecific activation of cardiac ATP sensitive K+ channels by epoxyeicosatrienoic acids: a structural determinant study. Mol Pharmacol 2002, 62:1076-1083.